Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
Historical Issues of Optic neuritis and Sensory Disorder in Persian Traditional Medicine.
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.
The risk of Bipolar Disorders in Multiple Sclerosis.
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
The value of the multiple sclerosis specialist nurse with respect to prevention of unnecessary emergency admission.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability.
Towards establishing MS prevalence in Latin America and the Caribbean.
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
Risk of vascular disease in patients with multiple sclerosis: a review.
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Functional assessment of magno, parvo and konio-cellular pathways; current state and future clinical applications.
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide.
Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
Psychiatric disorders in neurology.

Pages